血栓通治疗冠心病心绞痛的临床观察  被引量:20

Clinical effect on Xueshuantong Injection in the treatment of coronary heart disease and angina

在线阅读下载全文

作  者:曹辉[1] 卢长虹[1] 聂广邻 

机构地区:[1]四川省岳池县人民医院药剂科,四川岳池638300

出  处:《中国医药导报》2011年第21期14-16,共3页China Medical Herald

摘  要:目的:研究血栓通注射液治疗冠心病心绞痛的临床效果。方法:将100例冠心病心绞痛患者随机分为治疗组(50例)和对照组(50例)。两组常规给予西药抗心绞痛治疗,治疗组加用血栓通注射液。观察两组患者的心绞痛缓解,心电图心肌缺血改善情况,血脂、血液流变学各指标的变化。结果:治疗组心绞痛缓解总有效率(98%)明显高于对照组(80%)(P<0.01),两组治疗后心电图示心肌缺血改善情况、血脂、血液流变学各指标比较,差异均有统计学意义(P<0.01或P<0.05)。结论:血栓通注射液治疗冠心病心绞痛疗效显著,安全可靠,具有较高的临床应用价值。Objective: To study the clinical effect on Xueshuantong Injection in the treatment of coronary heart disease and angina.Methods: 100 patients with angina of coronary heart disease were randomly divided into treatment group(50 cases) and control group(50 cases).Patients in treatment group were treated with routine regimen and Xueshuantong Injection;patients in control group were treated with routine regimen.Indicators of the clinical manifestation of angina,myocardial ischemia judged by electrocardiogram,blood lipids and blood rheology in two groups were observed.Results: The total effective rate of improvement of clinical manifestation of angina were 98.00% and 80.00% in treatment group and control group respectively(P0.01);there were significant differences of improvement of myocardial ischemia judged by electrocardiogram,blood lipids and blood rheology between two groups after treatment(P0.01 or P0.05).Conclusion: Xueshuantong Injection has markedly effect with little side one on angina of coronary heart disease,it is worthy to use in application.

关 键 词:冠心病 心绞痛 血栓通注射液 

分 类 号:R541.4[医药卫生—心血管疾病]

 

参考文献:

正在载入数据...

 

二级参考文献:

正在载入数据...

 

耦合文献:

正在载入数据...

 

引证文献:

正在载入数据...

 

二级引证文献:

正在载入数据...

 

同被引文献:

正在载入数据...

 

相关期刊文献:

正在载入数据...

相关的主题
相关的作者对象
相关的机构对象